Saniona AB: Saniona to participate in multiple upcoming investor conferences
PRESS RELEASE March 1, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming investor
United States Trista Morrison Eventupdate Mar Redeye Investor Forum Investor Forum Chief Communications
Source: finanznachrichten.de